First Bankers Trust’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$497K Buy
44,597
+8,975
+25% +$109K 0.15% 112
2026
Q1
$497K Buy
35,622
+10,187
+40% +$143K 0.17% 106
2025
Q4
$366K Buy
25,435
+3,400
+15% +$51.1K 0.12% 117
2025
Q3
$351K Buy
22,035
+11,655
+112% +$192K 0.12% 115
2025
Q2
$184K Buy
+10,380
New +$202K 0.07% 139
2024
Q2
Sell
-12,525
Closed -$226K 125
2024
Q1
$226K Buy
+12,525
New +$227K 0.1% 123
2023
Q4
Sell
-15,550
Closed -$309K 116
2023
Q3
$309K Buy
+15,550
New +$295K 0.16% 97

Other funds holding BTAL

First Bankers Trust's BTAL Position: Q2 2026 in Review

First Bankers Trust increased its AGF US Market Neutral Anti-Beta Fund (BTAL) stake by 25% in Q2 2026, buying an estimated $109K and bringing the position to 44,597 shares worth $497K. The position accounts for 0.15% of the portfolio, ranked #112.

First Bankers Trust first reported a position in BTAL in Q3 2023 and has held it in 7 quarters since. The position peaked at $497K in Q1 2026. 93 funds tracked by Wall St. Rank hold BTAL as of Q2 2026.

  • First Bankers Trust held 44,597 shares of AGF US Market Neutral Anti-Beta Fund worth $497K as of Q2 2026.
  • First Bankers Trust bought 8,975 AGF US Market Neutral Anti-Beta Fund shares in Q2 2026, an estimated $109K.
  • AGF US Market Neutral Anti-Beta Fund made up 0.15% of First Bankers Trust's portfolio in Q2 2026, its #112 holding.
  • First Bankers Trust first reported a position in AGF US Market Neutral Anti-Beta Fund in Q3 2023 and has held it in 7 quarters since.
  • First Bankers Trust's AGF US Market Neutral Anti-Beta Fund position peaked at $497K in Q1 2026.
  • 93 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q2 2026.

Based on First Bankers Trust's 13F filing for Q2 2026, filed 9 Jul 2026.